GlassScriptPhysician profile
Dirk Roderi Hines
NPI 1245286590
$4,445.43
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,917 · 2020: $345 · 2021: $839 · 2022: $694 · 2023: $544 · 2024: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $650.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $660.35 | 2021-2023 | |
| Pfizer INC. | $457.34 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $421.91 | 2019-2022 | |
| Novo Nordisk INC | $393.81 | 2019-2023 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $281.28 | 2019-2021 | |
| Glaxosmithkline, LLC. | $251.85 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Sanofi-Aventis U.S. LLC | $211.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $208.14 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $205.83 | 2019-2021 | |
| Amgen INC. | $192.30 | 2019-2022 | |
| Exact Sciences Corporation | $123.58 | 2023-2024 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $116.55 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $107.68 | 2019-2022 | |
| Horizon Therapeutics Plc | $106.86 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $86.87 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $81.70 | 2021-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.28 | 2019-2022 | |
| Abbott Laboratories | $55.30 | 2024 | Freestyle Libre 3 |
| Phadia US INC. | $48.54 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.47 | 2019-2020 | |
| Radius Health, INC. | $38.40 | 2019 | |
| Esperion Therapeutics, INC. | $34.90 | 2022 | |
| Sunovion Pharmaceuticals INC. | $34.07 | 2021 | |
| Astellas Pharma US INC | $33.99 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $25.73 | 2019 | |
| Hikma Pharmaceuticals USA | $23.94 | 2019 | |
| Dexcom, INC. | $23.31 | 2021 | |
| Vanda Pharmaceuticals INC. | $22.17 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.95 | 2023 | Gvoke Hypopen |
| Eisai INC. | $19.45 | 2021 | |
| Antares Pharma, INC. | $14.79 | 2023 | Nocdurna, Tlando, Xyosted |
| Sanofi Pasteur INC. | $12.63 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.89 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.88 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dirk Hines listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.